Skip to content
LGBTQIA, Medical Health Aged Care

Dash Heath-Paynter confirmed as Health Equity Matters CEO

Health Equity Matter 2 mins read

Health Equity Matters, Australia’s HIV and LGBTIQA+ health federation, is pleased to announce the appointment of Dash Heath-Paynter as its new chief executive officer.

 

Dash takes on the leadership of Health Equity Matters after serving almost eight years as deputy CEO. During that period, Dash oversaw policy development, political advocacy and engagement. This encompassed the national community response to Mpox, including co-chairing the National Mpox Taskforce.

 

“We are delighted to confirm the appointment of Dash Heath-Paynter as our new chief executive,” Health Equity Matters President, Mark Orr AM, said. “Dash brings deep, sustained experience in HIV and LGBTIQA+ health advocacy and policy. Dash’s skills and experience will serve our communities well as we push for the virtual elimination of HIV transmission and a more robust community-led response to the health needs of LGBTIQA+ communities.”

 

Dash is a member of the Medical Services Advisory Committee (MSAC) PICO Advisory Sub-Committee (PASC); the Therapeutics Goods Administration (TGA) Advertising Consultative Committee, the National HIV PrEP Guidelines Committee and the National HIV Testing Policy Expert Reference Committee. 

 

“It is a profound honour and privilege to take on the executive leadership of the Health Equity Matters at this pivotal moment,” Dash Heath-Paynter said. “My predecessor, Adjunct Professor Darryl O’Donnell established strong foundations for us to make monumental progress towards better health responses for LGBTIQA+ people, the virtual elimination of HIV transmission and continuing support for people living with HIV. 

 

“We have an incredibly talented and motivated team at Health Equity Matters and we take seriously our role in protecting and promoting the partnership of researchers, clinicians, community and government that is at the centre of Australia’s HIV response.

 

“I look forward to working closely with the Federal Government to drive further progress for the communities we represent and serve.”

 

Prior to joining Health Equity Matters’ Dash worked as a senior policy analyst at Health Equity Matters’ Victorian member organisation, the Victorian AIDS Council, now Thorne Harbour Health.

 

Dash is an Adjunct Senior Lecturer at the Kirby Institute, at the University of New South Wales and holds degrees in law and arts. He is a graduate of the Harvard University Kennedy School of Government Executive Leadership Program.

 

Interview requests: Nick Lucchinelli 0422229032

 

More from this category

  • Medical Health Aged Care
  • 20/04/2024
  • 04:30
Dementia Australia

Join us TODAY for Bendigo Memory Walk & Jog

What: Dementia Australia’sBendigoMemory Walk & Jog When: Saturday 20 April, from 8am Who: More than 390 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Where: Bendigo Botanic Gardens, Bendigo For more information visit: www.memorywalk.com.au Walk or jog with us. We are in this together. Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people…

  • Contains:
  • Medical Health Aged Care, Science
  • 19/04/2024
  • 15:00
Monash University

Large-scale genetic study finds new link between Irritable Bowel Syndrome and the cardiovascular system

New research published today in the journal Cellular and Molecular Gastroenterology and Hepatology sheds light on disease mechanisms common to irritable bowel syndrome (IBS) and cardiovascular diseases (CVD). Led by Dr Leticia Camargo Tavares, a Postdoctoral Fellow at the Hypertension Research Laboratory within Monash University’s School of Biological Sciences, the study reveals novel insights into the genetic underpinnings of IBS, offering potential avenues for therapeutic intervention. IBS is one of the most prevalent gastrointestinal disorders globally, affecting up to 10 per cent of the population, with a disproportionate impact on women. It is characterised by a complex range of symptoms…

  • Medical Health Aged Care
  • 19/04/2024
  • 11:13
Gilead Sciences Australia

Australian community organisations addressing viral hepatitis receive AU$400,000 via global Gilead ALL4LIVER Grant program

– Gilead Sciences joins forces with World Hepatitis Alliance and experts to drive progress on viral hepatitis elimination targets – – Australian initiatives well represented in Gilead’s US$4 million global fund to empower local communities in the fight against viral hepatitis – Melbourne, Australia, 19 April 2024 – Today, on World Liver Day, Gilead Sciences Australia has announced nine local community organisations addressing viral hepatitis will receive a combined AU$400,000 via the global Gilead ALL4LIVER Grant. The recipients were selected by an independent external review panel of global experts, including the World Hepatitis Alliance. Australia has committed to achieving the…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.